Brain Scientific Inc. (BRSF) Poised to Contribute to Mental Health Research; Provides Technology to Map Brain Response to Psychedelic Treatment
BRSF has partnered with Ehave to conduct research connected to biochemical biomarkers concerning psychedelic drug administrationPsychedelic drugs show promise in treating neurological disorders, including chronic pain, depression, and PTSD, but more research is neededBRSF's E-Tattoo is poised to bring benefits of biomarkers to neurological and psychiatric research; allows monitoring of patient's brain activity in a non-intrusive way Brain Scientific (OTCQB: BRSF) has partnered with Ehave,…